Eyedaptic’s 3rd Patent Granted

Eyedaptic has been granted a third patent! 

This patent, along with the others, protects Eyedaptic’s intellectual property and low vision technology including Hybrid See Through, which enables Augmented Reality for low vision along with the image processing and machine learning software algorithms as well as the adaptive systems used to stimulate natural vision.

Hybrid see-through (HST) devices are designed specifically to utilize augmented reality by merging the most favorable aspects of both Video-See Through (VST) and Optical-See Through (OST) devices. HST devices possess the lightweight, open, and ergonomic form factor of OST platforms while retaining the processing power and immersive visual capabilities of a VST device. 

HSTs are a unique approach to low vision assistive devices emerging on the market with Eyedaptic’s patented designs. The HST is designed to cater to the low vision demographic and address issues prevalent in OST and VST devices. 

Of the various currently available options for low vision assistive devices, HST augmented reality technology is the solution that provides the optimal solution for low vision. An HST augmented pair of glasses designed for low vision people provides the most robust set of assistive features, conscious ergonomic considerations, and caters to the specific needs of the low vision demographic. This is why Eyedaptic has focused on developing our series of eye products. Eyedaptic’s extensive visual enhancements and autonomous algorithms are designed to offer a more natural viewing experience ensuring that every product released are some of the most accessible and easy-to-use hybrid see-through augmented reality tech currently available on the market.

About Eyedaptic

Eyedaptic is a privately held company that develops visual aid software, enabled by augmented reality hardware, for macular degeneration and other retinal diseases. The software goes beyond magnification to enable a fuller field of vision, and simulates natural vision for those suffering from central vision disorders such as AMD (age-related macular degeneration), to revitalize their quality of life.

For information contact us.